L'Occitane International S.A. (0973.HK)
HKD 33.8
(0.3%)
HKD 33.8
(0.3%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 876.16 Million EUR | 10.27% |
| 2022 | 794.56 Million EUR | -15.93% |
| 2021 | 945.16 Million EUR | 15.71% |
| 2020 | 816.84 Million EUR | -8.9% |
| 2019 | 896.68 Million EUR | 51.25% |
| 2018 | 592.84 Million EUR | 478.25% |
| 2017 | 102.52 Million EUR | 16.91% |
| 2016 | 87.69 Million EUR | -14.96% |
| 2015 | 103.12 Million EUR | -15.8% |
| 2014 | 122.48 Million EUR | 39.04% |
| 2013 | 88.08 Million EUR | -2.82% |
| 2012 | 90.64 Million EUR | 16.74% |
| 2011 | 77.64 Million EUR | 17.84% |
| 2010 | 65.89 Million EUR | -2.2% |
| 2009 | 67.37 Million EUR | -40.96% |
| 2008 | 114.11 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | 707.95 Million EUR | -10.9% |
| 2023 Q3 | 787.15 Million EUR | -0.76% |
| 2023 Q4 | 876.16 Million EUR | 11.31% |
| 2023 Q2 | 793.16 Million EUR | 12.04% |
| 2023 FY | 876.16 Million EUR | 10.27% |
| 2022 Q1 | 788.5 Million EUR | -16.57% |
| 2022 FY | 794.56 Million EUR | -15.93% |
| 2022 Q4 | 794.56 Million EUR | 11.57% |
| 2022 Q3 | 712.16 Million EUR | -18.76% |
| 2022 Q2 | 876.58 Million EUR | 11.17% |
| 2021 Q4 | 945.16 Million EUR | 11.01% |
| 2021 Q3 | 851.44 Million EUR | 24.58% |
| 2021 FY | 945.16 Million EUR | 15.71% |
| 2021 Q2 | 683.44 Million EUR | 15.49% |
| 2021 Q1 | 591.78 Million EUR | -27.55% |
| 2020 Q4 | 816.84 Million EUR | 10.63% |
| 2020 Q2 | 918.89 Million EUR | 11.89% |
| 2020 Q3 | 738.35 Million EUR | -19.65% |
| 2020 FY | 816.84 Million EUR | -8.9% |
| 2020 Q1 | 821.22 Million EUR | -8.41% |
| 2019 Q2 | 942.41 Million EUR | 12.32% |
| 2019 Q4 | 896.68 Million EUR | 12.44% |
| 2019 FY | 896.68 Million EUR | 51.25% |
| 2019 Q1 | 839.04 Million EUR | 41.53% |
| 2019 Q3 | 797.47 Million EUR | -15.38% |
| 2018 Q3 | 576.73 Million EUR | 441.73% |
| 2018 FY | 592.84 Million EUR | 478.25% |
| 2018 Q4 | 592.84 Million EUR | 2.79% |
| 2018 Q2 | 106.46 Million EUR | 18.45% |
| 2018 Q1 | 89.87 Million EUR | -12.33% |
| 2017 Q2 | 103.79 Million EUR | 17.57% |
| 2017 Q1 | 88.27 Million EUR | 0.66% |
| 2017 FY | 102.52 Million EUR | 16.91% |
| 2017 Q3 | 86.44 Million EUR | -16.71% |
| 2017 Q4 | 102.52 Million EUR | 18.61% |
| 2016 Q3 | 71.39 Million EUR | -31.64% |
| 2016 FY | 87.69 Million EUR | -14.96% |
| 2016 Q1 | 88.78 Million EUR | -13.9% |
| 2016 Q2 | 104.44 Million EUR | 17.63% |
| 2016 Q4 | 87.69 Million EUR | 22.84% |
| 2015 Q2 | 124.7 Million EUR | 13.4% |
| 2015 Q3 | 87.23 Million EUR | -30.04% |
| 2015 Q4 | 103.12 Million EUR | 18.21% |
| 2015 FY | 103.12 Million EUR | -15.8% |
| 2015 Q1 | 109.96 Million EUR | -10.22% |
| 2014 Q2 | 118.23 Million EUR | 11.67% |
| 2014 FY | 122.48 Million EUR | 39.04% |
| 2014 Q4 | 122.48 Million EUR | 13.12% |
| 2014 Q3 | 108.27 Million EUR | -8.43% |
| 2014 Q1 | 105.87 Million EUR | 20.19% |
| 2013 Q4 | 88.08 Million EUR | 13.74% |
| 2013 Q2 | 99.35 Million EUR | 10.89% |
| 2013 Q1 | 89.6 Million EUR | -1.15% |
| 2013 FY | 88.08 Million EUR | -2.82% |
| 2013 Q3 | 77.44 Million EUR | -22.05% |
| 2012 FY | 90.64 Million EUR | 16.74% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 Q3 | 80.86 Million EUR | -13.0% |
| 2012 Q4 | 90.64 Million EUR | 12.09% |
| 2012 Q2 | 92.94 Million EUR | 0.0% |
| 2011 Q4 | 77.64 Million EUR | 0.0% |
| 2011 FY | 77.64 Million EUR | 17.84% |
| 2011 Q2 | 87.3 Million EUR | 0.0% |
| 2010 Q2 | 91.08 Million EUR | 0.0% |
| 2010 Q4 | 65.89 Million EUR | 0.0% |
| 2010 FY | 65.89 Million EUR | -2.2% |
| 2009 Q4 | 67.37 Million EUR | 0.0% |
| 2009 FY | 67.37 Million EUR | -40.96% |
| 2008 FY | 114.11 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 186.28 Million HKD | -370.332% |
| Innovative Pharmaceutical Biotech Limited | 917.44 Million HKD | 4.5% |
| China Overseas Nuoxin International Holdings Limited | 49.93 Million HKD | -1654.685% |
| Prosperous Future Holdings Limited | 20.89 Million HKD | -4093.39% |
| Huasheng International Holding Limited | 338.39 Million HKD | -158.917% |
| Fourace Industries Group Holdings Limited | 3.24 Million HKD | -26942.191% |
| Evergreen Products Group Limited | 615 Million HKD | -42.466% |
| EC Healthcare | 1.6 Billion HKD | 45.366% |
| Ming Fai International Holdings Limited | 57.56 Million HKD | -1422.154% |
| Blue Moon Group Holdings Limited | 158.89 Million HKD | -451.409% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | -532.867% |
| Takbo Group Holdings Limited | 11.53 Million HKD | -7498.361% |
| Hyfusin Group Holdings Limited | 18.36 Million HKD | -4671.372% |